
Directorship Details
As on 31st December 2024- Max Healthcare Institute Limited
- Alembic Pharmaceuticals Limited
- Elecon Engineering Company Limited
- Shreno Engineering Limited
- Incozen Therapeutics Private Limited
- Alembic Global Holding SA
- Alembic Pharmaceuticals Inc
- Alembic Pharmaceuticals Australia Pty Limited
- Alembic Pharmaceuticals Europe Limited
- Alembic Pharmaceuticals Canada Limited
- Alnova Pharmaceuticals SA
- Rhizen Pharmaceuticals AG
- Dahlia Therapeutics SA
- Alembic Pharmaceuticals S.A de C.V
- Viramya Packlight LLP
Pranav Amin
Lead Independent DirectorMr. Pranav Amin is an Independent Director of our Company. He was appointed on the Board of our Company in August, 2022.
Mr. Amin is also designated as the Lead Independent Director of the Company.
With over 23 years of professional experience, he presently serves as the Managing Director of Alembic Pharmaceuticals Ltd. (Alembic Pharmaceuticals), part of the Alembic Group established in 1907 in Vadodara, India.
He is a recipient of the Forbes NextGen Entrepreneur of the year 2016. He is also closely involved in charitable activities of Alembic Group, as a way to give back to the society. He is a trustee of Uday Education Society, which runs four schools in Vadodara and also a trustee of Bhailal Amin General Hospital.
Academic Qualifications
- Double Major in Economics and Industrial Management from the Carnegie Mellon University in Pittsburgh, USA
- Master of Business Administration in International Management from Thunderbird, The American Graduate School of International Management
Directorship Details
As on 31st December 2024- Max Healthcare Institute Limited
- Alembic Pharmaceuticals Limited
- Elecon Engineering Company Limited
- Shreno Engineering Limited
- Incozen Therapeutics Private Limited
- Alembic Global Holding SA
- Alembic Pharmaceuticals Inc
- Alembic Pharmaceuticals Australia Pty Limited
- Alembic Pharmaceuticals Europe Limited
- Alembic Pharmaceuticals Canada Limited
- Alnova Pharmaceuticals SA
- Rhizen Pharmaceuticals AG
- Dahlia Therapeutics SA
- Alembic Pharmaceuticals S.A de C.V
- Viramya Packlight LLP
Notes
- Does not have any family relationships with any directors of the Company;
- Does not have any conflict of interest with the Company in terms of Code of Conduct for Board of Directors and Senior Management of the Company;
- Does not have any order disqualifying him for appointment as a director passed by a court or tribunal, and the order is in force as per section 164 of the Companies Act, 2013.